doi:10.3969/j.issn.1671-2587.2024.06.021

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (6): 843-848.DOI: 10.3969/j.issn.1671-2587.2024.06.021

Previous Articles Next Articles

Received:2024-03-07 Online:2024-12-20 Published:2024-12-20

[1] YANG J H,FAN D,XIE D F,et al.First donor haemovigilance system at a national level in China:establishment and improvement[J]. Vox Sang,2023,118(5):357-366.
[2] 杨俊鸿,陈敏,何涛,等. 我国全血献血者献血不良反应发生率Meta分析[J]. 中国输血杂志,2021,34(4):376-381.
[3] 杨俊鸿,黄霞,何涛,等. 献血不良反应监测进展[J]. 临床输血与检验,2020,22(5):556-560.
[4] Grading Severity of Blood Donor Adverse Events Tool. User Brochure AABB[EB/OL].[2024-2-29].https://www.aabb.org/docs/default-source/default-document-library/resources/severity-grading-tool-for-donor-adverse-events.pdf?sfvrsn=ff563263_6.
[5] 中国输血协会. 血液安全监测指南[S]. 2019.
[6] WIERSUM-OSSELTON J C,POLITIS C,RICHARDSON C,et al. Complications of blood donation reported to haemovigilance systems:analysis of eleven years of international surveillance[J].Vox Sang,2021,116(6):628-636.
[7] RADOVČIĆ M K,LJUBIČIĆ J,OČIĆ T,et al.Blood collection failures from a blood establishment perspective[J].Transfus Med,2021,31(2):88-93.
[8] THIJSEN A,THORPE R,DAVISON T E,et al.The vasovagal reaction experience among blood donors:a qualitative study of factors that affect donor return[J].Soc Sci Med,2021,282:114142.
[9] BRUNSON D C,BELANGER G A,SUSSMANN H,et al.Factors associated with first-time and repeat blood donation:adverse reactions and effects on donor behavior[J].Transfusion,2022,62(6):1269-1279.
[10] YOUNG P,CROWDER L,STEELE W,et al.Frequency of rare,serious donor reactions:international perspective[J].Transfusion,2021,61(6):1780-1788.
[11] WIERSUM-OSSELTON J,PRINSZE F,VAN DEN BREKEL E,et al.An intervention study for the prevention of vasovagal reactions and evaluating donors' experience:analysis of donors' return for subsequent donation[J].Vox Sang,2022,117(3):313-320.
[12] IBRAHIM N N,MOHD NOOR N H,ZULKAFLI Z.Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia[J].Transfus Clin Biol,2023,30(2):238-243.
[13] International Society of Blood Transfusion, Working Party on Haemovigilance, Working Group on Complications Related to Blood Donation, European Haemovigilance Network.Standard for Surveillance of Complications Related to Blood Donation[EB/OL].[2024-2-29].http://www.isbt-web.org/members_only/files/society/StandardSurveillanceDOCO.pdf.
[14] Haemovigilance Network and the AABB Donor Haemovigilance Working Group.Standard for Surveillance of Complications Related to Blood Donation.ISBT working party on haemovigilance in collaboration with the International [EB/OL].(2014-12-11)[2024-2-29].https://www.isbtweb.org/isbt-working-parties/haemovigilance/resources.html.
[15] International Society of Blood Transfusion, Rationale for changes from 2008 to 2014 classification of adverse donor events[EB/OL].(2014-12-11) [2024-2-29].http://www.isbtweb.org/working-parties/haemovigilance/definitions.
[16] 郭永建. 国际输血协会献血并发症监测标准(2014年修订版)主要内容及其启示[J]. 中国输血杂志,2015,28(2): 223-229.
[17] 陈辉,徐健,郭瑾,等.国家卫生行业标准《献血不良反应分类指南》导读[J]. 中国输血杂志,2017,30(9):1080-1084.
[18] LAND K J,TOWNSEND M,GOLDMAN M,et al.International validation of harmonized definitions for complications of blood donations[J].Transfusion,2018,58(11):2589-2595.
[19] TOWNSEND M,KAMEL H,VAN BUREN N,et al.Development and validation of donor adverse reaction severity grading tool:enhancing objective grade assignment to donor adverse events[J].Transfusion,2020,60(6):1231-1242.
[20] US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology for Adverse Events Version 5.0.[EB/OL].(2017-11-27)[2024-2-29].http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
[21] RONEY J K,WHITLEY B E,JOHNSTON L,et al.Should adding pain,oxygen saturation and physical assessment to vital signs become the new standard of care for detecting blood transfusion reactions?[J].Vox Sang,2023,118(2):109-120.
[22] FREITES-MARTINEZ A,SANTANA N,ARIAS-SANTIAGO S,et al.Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies[J].Actas Dermosifiliogr (Engl Ed),2021,112(1):90-92.
[23] HUTCHESON K A,BARBON C E A,ALVAREZ C P,et al. Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria:validation of DIGEST version 2[J].Cancer,2022,128(7):1458-1466.
[24] 陈辉,徐健,郭瑾,等. 国际输血行业标准《献血不良反应严重程度分级方法》主要内容及其启示[J]. 中国输血杂志,2022,35(1):124-127.
[25] 国家卫生计生委. 献血不良反应分类指南[S]. 2017.
[26] KAUR S,MITTAL K,KAUR R,et al.Reporting of delayed adverse donor reactions in whole blood donors:just the tip of an iceberg![J].Transfus Clin Biol,2022,29(2): 141-146.
[27] GUPTA A M,BAJPAI M.Delayed adverse reactions in whole blood donors:importance of active surveillance in identifying the missing gaps in the donor safety[J].Indian J Med Res,2023,157(1):30-36.
[28] MIKKELSEN C,PAARUP H M,BRUUN M T,et al.The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration[J].Vox Sang,2022,117(3):321-327.
[29] 刘黎燕,郑青青,徐雪梅. 《献血不良反应分类指南》运用实施体会[J]. 中国输血杂志,2020,33(12):1306-1308.
[30] 任爱民,居兵,刘媛媛,等. 多家血液中心献血不良反应监测工作开展情况分析[J]. 中国输血杂志,2022,35(4): 365-368.
[31] 张丽娜,王庆明,陆江洋,等. 石家庄地区无偿献血者不良反应及影响因素分析[J]. 华南预防医学,2022,48(8):977-980.
[32] PICCININI V,MARANO G,CATALANO L,et al.Vasovagal reactions in whole blood and apheresis donors:a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy[J].Blood Transfus,2022,20(4):281-291.
[33] PAALVAST Y,PADILLA N D,BRUIJNS S,et al.Donor complication rates in whole blood,plasma and platelet donors:age versus experience[J].Transfusion,2024.
[34] BISHT A,ARORA S,PATIDAR G,et al.Knowledge assessment of a donor adverse reaction severity grading tool by the National Blood Donor Vigilance Programme of India[J].Vox Sang,2023,118(9):721-729.
[35] CHO J H,RAJBHANDARY S,VAN BUREN N L,et al.The safety of COVID-19 convalescent plasma donation:a multi-institutional donor hemovigilance study[J].Transfusion,2021,61(9):2668-2676.
[36] Affiliated to the Royal College of Pathologists.The2021 Annual SHOT Report[EB/OL].[2024-2-29].https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2021-FINAL-bookmarked-V3-November.pdf.
[37] Affiliated to the Royal College of Pathologists.The2022 Annual SHOT Report[EB/OL].[2024-2-29].https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2022-FINAL-Bookmarked-1.pdf.
[38] 中国输血协会血液安全监测专业委员会. 2020年血液安全监测报告[EB/OL]. (2021-9-8)[2024-2-29].http://www.cqsbt.org.cn/data/attachment/2023/01/08/380917001673152504.pdf.
[39] 中国输血协会血液安全监测专业委员会. 2021年血液安全监测报告[EB/OL]. (2022-9-15)[2024-2-29].http://www.cqsbt.org.cn/data/attachment/2023/01/08/060498001673152527.pdf.
[40] 中国输血协会血液安全监测专业委员会. 2022年血液安全监测报告[EB/OL]. (203-10-30)[2024-2-29].http://www.cqsbt.org.cn/data/attachment/2023/10/30/800519001698650805.pdf.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	ZHUANG Yuan, YU Yang. Strengthening the Application of Centrifugal Technology and Establishing a Combined Apheresis/Blood Purification System in the Department of Transfusion Medicine [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 721-725.
[2]	LIU Xiaomin, ZHUANG Yuan, YU Yang. Survey Report on Current Status of Transfusion Therapy in Transfusion Medicine Departments of Medical Institutions Across China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 740-743.
[3]	SHEN Qianyun, CHENG Wenguo, HOU Shuning, YAO Genghong. Differential Expression and Clinical Significance of Vascular Cell Adhesion Molecule-1 in Plasma of Neonates with ABO Hemolytic Disease [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 744-749.
[4]	WANG Danting, LONG Honghui, NIU Yingying, HUANG Chunyan. Analysis and Clinical Significance of Minor Cross-match Incompatibility with Micro-column Gel Test [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 750-754.
[5]	CHE Yang, LIU Zheng, ZHOU Xiaoyu. Retrospective Analysis of the Efficacy of Postoperative Plasma Transfusion in Patients with Primary Liver Cancer Undergoing Liver Resection [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 755-761.
[6]	ZHENG Yan, WANG Wenting, YANG Longfei, WANG Qiong, MU Shijie. Serological Characteristics and DNA Sequence Analysis of Patients with RhD Variant [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 762-765.
[7]	LIANG Chunyan, DUAN Li, LIU Youying, LIU Fangjiu. Risk Factors and Predictive Models of Transfusion-associated Circulatory Overload in Hospitalized Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 771-776.
[8]	CAI Yin, CHEN Zhiying, JIANG Ling, REN Yana, ZHENG Lan, ZHOU Guoping. Screening Analysis of HLA Antibodies of Blood Donors in Shanghai Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 777-780.
[9]	GUO Rui, HOU Yun, SU Changshan, et al. Assessing the Residual Risk of Hepatitis B Virus Transmission via Blood Transfusion in 21 Chinese Blood Centers from 2018 to 2022 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 781-786.
[10]	LI Yan, ZHOU Liling, MA Zhaoze, ZHU Kaijie, WANG Chenlong. Genotypic Identification and Sequence Analysis of B/AB Subtypes in 25 Cases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 787-791.
[11]	LI Xin, YANG Junhong. Meta Analysis of Incidence of Platelet Antibody in Pregnant Women in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 805-811.
[12]	MING Jing, DING Kaiyang, HU Maogui, WANG Xinchen. Efficacy of Avatrombopag Combined with rhTPO for Thrombocytopenia Treatment in Patients with Hematologic Malignancies after Autologous Hematopoietic Stem Cell Transplantation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 812-817.
[13]	WANG Jiaqi, XIAO Jun, LI Cuiying. Research Progress of mTOR Pathway in Regulating Self-renewal and Differentiation of Hematopoietic Stem Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 818-824.
[14]	WANG Shujun, LI Zhaojie, YANG Yi, LUAN Jianfeng. Platelet-derived Products in Wound Healing [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 825-834.
[15]	REN Daoju, LI Xiaowei, LI Cuiying. Advances in Non-invasive Cell-free Fetal DNA Blood Group Testing in Prenatal Diagnosis [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 835-842.